Cargando…
Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
Patients with non-small cell lung cancer (NSCLC) can develop strong drug resistance following long-term treatment with platinum-based drugs. Increasing doses of chemotherapeutic drugs fail to obtain better results, and serious complications occur. It has been demonstrated that upregulation of excisi...
Autores principales: | Chen, Yun, Hong, Chaojin, Chen, Xiaochen, Qin, Zhiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491090/ https://www.ncbi.nlm.nih.gov/pubmed/32963615 http://dx.doi.org/10.3892/ol.2020.12072 |
Ejemplares similares
-
Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer
por: Chen, Ying-Yi, et al.
Publicado: (2018) -
Curcumin, demethoxycurcumin, and bisdemethoxycurcumin induced caspase-dependent and –independent apoptosis via Smad or Akt signaling pathways in HOS cells
por: Huang, Cheng, et al.
Publicado: (2020) -
Effects of demethoxycurcumin on the viability and apoptosis of skin cancer cells
por: Wu, Yaoqun, et al.
Publicado: (2017) -
Scutellarin Increases Cisplatin-Induced Apoptosis and Autophagy to Overcome Cisplatin Resistance in Non-small Cell Lung Cancer via ERK/p53 and c-met/AKT Signaling Pathways
por: Sun, Chao-Yue, et al.
Publicado: (2018) -
Combination therapy with cisplatin and nifedipine induces apoptosis in cisplatin-sensitive and cisplatin-resistant human glioblastoma cells.
por: Kondo, S., et al.
Publicado: (1995)